Skip to main content

Table 4 Incidence of AEs within 30 days before surgery according to CTCAE and Clavien-Dindo gradesa

From: Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy

 

CD0 group (n = 61)

CD1/2 group (n = 44)

CD3/4 group (n = 10)

Total (n = 115)

P Value

Anemia

    

0.724

     Grade 0

23 (20.0)

13 (11.3)

2 (1.7)

38 (33.0)

 

     Grade 1/2

36 (31.3)

30 (26.1)

8 (7.0)

74 (64.3)

 

     Grade 3/4

2 (1.7)

1 (0.9)

0 (0.0)

3 (2.6)

 

Leukopenia

   

0.196

     Grade 0

38 (33.0)

27 (23.5)

10 (8.7)

75 (65.2)

 

     Grade 1/2

19 (16.5)

15 (13.0)

0 (0.0)

34 (29.6)

 

     Grade 3/4

4 (3.5)

2 (1.7)

0 (0.0)

6 (5.2)

 

Neutropenia

   

0.740

     Grade 0

38 (33.0)

26 (22.6)

8 (7.0)

72 (62.6)

 

     Grade 1/2

16 (13.9)

12 (10.4)

2 (1.7)

30 (26.1)

 

     Grade 3/4

7 (6.1)

6 (5.2)

0 (0.0)

13 (11.3)

 

Lymphocytopenia

   

0.720

     Grade 0

31 (27.0)

19 (16.5)

6 (5.2)

56 (48.7)

 

     Grade 1/2

27 (23.5)

24 (20.9)

4 (3.5)

55 (47.8)

 

     Grade 3/4

3 (2.6)

1 (0.9)

0 (0.0)

4 (3.5)

 

Thrombocytopenia

   

0.577

     Grade 0

45 (39.1)

34 (29.6)

9 (7.8)

88 (76.5)

 

     Grade 1/2

16 (13.9)

10 (8.7)

1 (0.9)

27 (23.5)

 

Total AEs

 

0.421

     Grade 0

14 (12.2)

8 (7.0)

1 (0.9)

23 (20.0)

 

     Grade 1/2

36 (31.3)

28 (24.3)

9 (7.8)

73 (63.5)

 

     Grade 3/4

11 (9.6)

8 (7.0)

0 (0.0)

19 (16.5)

 
  1. AEs adverse events, CTCAE common terminology criteria for adverse events
  2. aData are presented as number (incidence)